Table 1.
Relationship between GPX2 expression and clinicopathological characteristics of cervical patient
| Characteristics | Total | IOD (mean) ≤100 | IOD (mean) ≥100 | P-value |
|---|---|---|---|---|
| Age (years) | 0.904 | |||
| <53 | 55 | 30 | 25 | |
| ≥53 | 45 | 24 | 21 | |
| Size (cm) | 0.450 | |||
| ≤2 | 35 | 20 | 15 | |
| >2 | 65 | 32 | 33 | |
| FIGO stage | <0.001*** | |||
| 35 | 30 | 5 | ||
| 32 | 10 | 22 | ||
| 20 | 4 | 16 | ||
| 13 | 1 | 12 | ||
| Histological type | 0.346 | |||
| Squamous cell carcinoma | 82 | 36 | 46 | |
| Adenocarcinoma | 17 | 10 | 7 | |
| Adeno-acanthoma | 1 | 0 | 1 | |
| Lymph node metastasis | <0.001*** | |||
| Absent | 67 | 40 | 27 | |
| Present | 33 | 5 | 28 |
Notes: Cervical patient were divided into GPX2 low and GPX2 high group according to the cut off value. (n = 100). p< 0.05 was considered statistic significant. Differences among variables were evaluated SPSS application. ***p<0.001.
Abbreviations: GPX2, Glutathione peroxidase; IOD (mean), the mean of integrated optical density; IOD ≤100, low GPX2 expression.